Диссертация_Яковлев_ДА. Диссертация на соискание ученой степени кандидата медицинских наук Научный доктор медицинских наук, профессор Немков Александр Сергеевич
 Скачать 2.26 Mb.
|
|
124. Knuesel P., Nanz D., Wyss Ch., et al. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance. // Circulation. – 2003. – Vol. 108. – № 9. – P. 1095 – 1100. 125. Kübler W. Metabolism of the ischemic myocardium - clinical aspects. // Z. Kardiol. – 1984. – Vol. 73. – Suppl.2. – P. 107 – 112. 126. Lee K., Marwick T., Cook S., et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. // Circulation. – 1994. – Vol. 90 . – № 6. – P. 2687 – 2694. 127. Liu J., Liu Z., Chen A., et al. Mid-term results of coronary bypass graft surgery in patients with ischemic left ventricular systolic dysfunction and no detected myocardial viability. // Int. Cardiovasc. and Thorac. Surg. – 2016. – Vol. 22. – № 4. – P. 738 – 743. 128. Lund G., Freyhoff J., Schwaiger M., et al. Prediction of left ventricular functional recovery by dobutamine echocardiography, F-18 deoxyglucose or 99mTc sestamibi nuclear imaging in patients with chronic myocardial infarction. // Cardiol. – 2002. – Vol. 98. – № 4. – P. 202 – 209. 129. Marber M. Viewpoint: stunning and longterm perfusion-contraction matching are clinically indistinguishable components of clinical hibernation and separation, even if practical, is unlikely to matter. // Basic Res. Cardiol. – 1997. – Vol. 92. – Suppl. 2. – P. 26 – 29. 130. Marwick T., Zuchowski C., Lauer M., et al. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. // J. Am. Coll. Cardiol. – 1999. – Vol. 33. – № 3. – P. 750 – 758. 131. Meluzin J., Cerny J., Frelich M., et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary 158 artery disease and left ventricular dysfunction. Investigators of this multicenter study. // J. Am. Coll. Cardiol. – 1998. – Vol. 32 . – № 4. – P. 912 – 920. 132. Mentzer R., Jr. Ischemic preconditioning: how close are we to therapeutic implementation? // Ann. Thorac. Surg. – 2000. – Vol. 70. – № 2. – P. 356 – 357. 133. Murashita T., Makino Y., Kamikubo Y., et al. Quantitative gated myocardial perfusion single photon emission computed tomography improves the prediction of regional functional recovery in akinetic areas after coronary bypass surgery: useful tool for evaluation of myocardial viability. // J. Thorac. Cardiovasc. Surg. – 2003. – Vol. 126. – № 5. – P. 1328 – 1334. 134. Murry C., Jennings R., Reimer K. Precoriditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. // Circulation. – 1986. – Vol. 74. – № 5. – P. 1124 – 1136. 135. Nakamura M. Myocardial ischemia. // Jpn. Circ. J. – 1985. – Vol. 49. – P. 1 – 12. 136. Nakata T., Hashimoto A et al. Cardiac BMIPP imaging in acute myocardial infarction. // J. Card. Imaging - 1999. – Vol. 15. – № 1. – P. 21 – 26. 137. Narula J., Haider N., Virmani R., et al. Apoptosis in myocytes in end-stage heart failure. // N. Engl. J. Med. – 1996. – Vol. 335. – P. 1182 – 1189. 138. Nichols A., Pearson M., Sciacca R., et al. Left ventricular mechanical efficiency in coronary artery disease. // J. Am. Coll. Cardiol. – 1986. – Vol.7. – № 2. – P. 270 – 279. 139. Nienaber C., Brunken R., Sherman C., et al. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. // J. Am. Coll. Cardiol. – 1991. – Vol. 18. – № 4. – P. 966 – 978. 140. O'Shaughnessy L. Surgical treatment of cardiac ischemia. // Lancet. – 1937. – Vol.1. – P. 185 – 190. 141. Ottani F., Galvani M., Ferrini D., et al. Prodromal angina limits infarct size. A role for ischemic preconditioning. // Circulation. – 1995. – Vol. 91. – № 2. – P. 291 – 297. 159 142. Pagano D., Camici P., Naguesh S., et al. Relation of contractile reserve of hibernating myocardium to myocardial structure in humans. // Circulation. – 2000. – Vol. 102. – № 25. – Р. e189 – e190. 143. Pagano D., Fath-Ordoubadi F., Beatt K., et al. Effects of coronary revascularisation on myocardial blood flow and coronary vasodilator reserve in hibernating myocardium. // Heart. – 2001. – Vol. 85. – № 2. – P. 208 – 212. 144. Pasini P., Ferrari G., Cremona G., et al. Revascularization of severe hibernating myocardium in the beating heart: early hemodynamic and metabolic features. // Ann. Thorac. Surg. – 2001. – Vol.71. – №1. – P.176 – 179. 145. Pelberg R., Spotnitz W., Bin J., et al. Mechanism of myocardial dysfunction in the presence of chronic coronary stenosis and normal resting myocardial blood flow: clinical implications. // J. Am. Soc. Echocardiogr. – 2001. – Vol. 14. – P. 1047 – 1056. 146. Pepper J. Surgery for hibernation. // Heart. – 2004. – Vol. 90. – № 2. – P. 144 – 145. 147. Pitt M., Dutka D., Pagano D., et al. The natural history of myocardium awaiting revascularisation in patients with impaired left ventricular function. // Eur. Heart J. – 2004. – Vol. 25. – № 6. – P. 500 – 507. 148. Rahimtoola S. Concept and evaluation of hibernating myocardium. // Annu. Rev. Med. – 1999. – Vol. 50. – P. 75 – 86. 149. Rahimtoola S. Coronary bypass surgery for chronic angina - 1981. A perspective. // Circulation. – 1982. – Vol. 65. – № 2. – P. 225 – 241. 150. Rahman I., Bonser R. Hibernation/stunning: clinical perspective. // Heart Metab. – 2009. – Vol. 42. – P. 34–37. 151. Reimer K.A., Murry C.E., Yamasawa I., et al. Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. // Am. J. Physiol. – 1986. – Vol. 251. – № 6. – Р. H.1306 – Н.1315. 152. Remme WJ., Swedberg K. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Guidelines for the 160 diagnosis and treatment of chronic heart failure. // Eur. Heart J. – 2001. – Vol.22. – № 16 – P. 1527 – 1560. 153. Rezkalla S., Kloner R. Preconditioning in humans. // Heart Fail. Rev. – 2007. – Vol. 12. – № 3-4. – P. 201 – 206. 154. Rinaldi C., Masani N., Linka A., et al. Effect of repetitive episodes of exercise induced myocardial ischaemia on left ventricular function in patients with chronic stable angina: evidence for cumulative stunning or ischaemic preconditioning? // Heart. – 1999. – Vol. 81. – P. 404 – 411. 155. Rosamond W, Flegal K, Furie K, Go A, et al. Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. // Circulation. – 2008. – Vol. 117. – P. e25 – e146. 156. Ross J. Jr. Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation. // Circulation. – 1991. – Vol. 83. – № 3. – P. 1076 – 1083. 157. Samady H., Elefteriades J., Abbott B., et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. // Circulation. – 1999. – Vol. 100 . – № 12. – P. 1298 – 1304. 158. Sato H., Iwasaki T., Toyama T. et al. Clinical investigations. Prediction of functional recovery after revascularization in coronary artery disease using 18F-FDG and 123I-BMIPP SPECT. // Chest. – 2000. – Vol. 117 . – № 1. – P. 65 – 72. 159. Schinkel A., Bax J., Poldermans D. et al. Hibernating myocardium: diagnosis and patient outcomes. // Curr. Probl. Cardiol. – 2007. – Vol. 32. – № 7. – P. 375 – 410. 160. Schott R., Rohmann S., Braun E., Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. // Circ. Res. – 1990. – Vol. 66. – № 4. – P. 1133 – 1142. 161 161. Schulz R., Heusch G. Hibernating myocardium. // Heart. – 2000. – Vol. 84. – № 6. – P. 587 – 594. 162. Schwarz E., Schaper J., vom Dahl J., et al. Myocyte degeneration and cell death in hibernating human myocardium. // J. Am. Coll. Cardiol. – 1996. – Vol. 27. - № 7. – P. 1577 – 1585. 163. Schwarz E., Schoendube F., Kostin S., et al. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. // Am. Coll. Cardiol. – 1998. – Vol. 31. – № 5. – P. 1018 – 1026. 164. Shabana A., El-Menyar A. Myocardial viability: what we knew and what is new. // Cardiol. Res. and Pract. – 2012. – 1 - 13. doi: 10.1155/2012/(607487). 165. Shivalkar B., Maes A., Borgers M., et al. Only hibernating myocardium invariably shows early recovery after coronary revascularization. // Circulation. – 1996. – Vol. 94 . – № 3. – P. 308 – 315. 166. Speechly-Dick M., Baxter G., Yellon D., et al. Ischaemic preconditioning protects hypertrophied myocardium. // Cardiovasc. Res. – 1994. – Vol. 28. – № 7. – P. 1025 – 1029. 167. Stipac A., Stanković I., Vidaković R., et al. Effect of myocardial revascularisation on left ventricular systolic function in patients with and without viable myocardium: should non-viable segments be revascularised? // Heart. – 2013. – Vol. 99. – № 23. – P. 1749 – 1754. 168. Stremmel W. Fatty acid uptake in the heart: update 1998. // Nucl. Med. (Stuttg) – 1998. – Vol. 37. – Suppl. – Р. S1 – S4. 169. Taki J., Nakajima K., Matsunari I. et al. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine- 123 BMIPP. // J. Nucl. Med. - 1997. – Vol. 38. – № 4. – P. 1503 – 1510. 170. Tamaki N., Morita K., Kuge Y. et al. The role of fatty acids in cardiac imaging. // J. Nucl. Med. - 2000. – Vol. 41. – № 9. – P. 1525 – 1534. 162 171. Tamaki N., Tadamura E., Kawamoto M. et al. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alteration in ischemic myocardium. // J. nucl. Med. – 1995. – Vol. 36. – № 11. – Р. 1974 – 1980. 172. Tashiro T., Todo K., Haruta Y., et al. Coronary artery bypass surgery in patients with poor left ventricular function. // Kyobu Geka. – 1993. – Vol. 46. – № 5. – P. 385 – 390. 173. Tatoulis J. Total arterial coronary revascularization – patient selection, stenoses, conduits, targets. // Ann. Cardiothorac. Surg. – 2013. – Vol. 2. – № 4. – Р. 499 – 506. 174. Tennant R., Wiggers C. Effect of coronary occlusion on myocardial contraction. // Am. J. Physiol. – 1935. – Vol. 112. – P. 351 – 361. 175. Thompson S., Raisbeck M. Cardiopericardiopexy; the surgical treatment of coronary arterial disease by the establishment adhesive pericarditis. // Amer. inter. dud. – 1942. – Vol. 16. – Р. 495 – 520. 176. Tio R., Dabeshlim A, Siebelink H-M. et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. // J. Nucl. Med. – 2009. – Vol. 50. – P. 214 –219. 177. Topol E., Weiss J., Guzman P., et al. Immediate improvement of dysfunctional myocardial segments after coronary revascularization: detection by intraoperative transesophageal echocardiography. // J. Am. Coll. Cardiol. – 1984. – Vol. 4. – № 6. – P. 1123 – 1134. 178. Tsubokawa A., Lee J.D., Shimuzi H. et al. Recovery of perfusion, glucose utilization and fatty acid utilization in stunned myocardium. // J. Nucl. Med. – 1997. – Vol. 38. – № 12. – P. 1835 – 1837. 179. Underwood S., Bax J., vom Dahl J., et al. Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. // Eur. Heart J. – 2004. – Vol. 25. – № 10. – P. 815 – 836. 163 180. Vanoverschelde J-L. Myocardial viability in man: state of the art and directions to pursue. // Bull. Mem. Acad. R. Med. Belg. – 1999. – Vol. 154. – № 1 . – P. 91 – 96. 181. Vanoverschelde J-L., Wijns W. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. // Circulation. – 1993. – Vol. 87. – № 5. – P. 1513 – 1523. 182. Venugopal V., Ludman A., Yellon D., et al. ‘Conditioning’ the heart during surgery. // Eur. J. Cardiothorac. Surg. – 2009. – Vol. 35. – Р. 977 – 987. 183. Verma S., Fedak P., Weisel R., et al. Fundamentals of reperfusion injury for the clinical cardiologist. // Circulation. – 2002. – Vol. 105. – № 20. – P. 2332 – 2336. 184. Vineberg A., Jewelt B. Development of an anastomosis between the coronary vessels and transplanted internal mammary artery. // Canad. med. Ass. J. – 1947. – Vol. 56. – P. 609 – 614. 185. Wijns W., Vatner S., Camici P. Hibernating myocardium. // The New Engl. Jour. of Med. – 1998. – Vol. 339. – № 3. – P. 173 – 181. 186. Wu Y-W., Tadamura E., Yamamuro M., et al. Comparison of contrast- enhanced MRI with 18F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease. // J. Nucl. Med. – 2007. - Vol. 48. – № 7. – P. 1096 – 1103. 187. Yellon D., Alkhulaifi A., Pugsley W., et al. Preconditioning the human myocardium. // Lancet. – 1993. – Vol. 342. – № 8866. – P. 276 – 277. 188. Yellon D., Dana A. The preconditioning phenomenon: a tool for the scientist or a clinical reality? // Circ. Res. – 2000. – Vol. 87 - № 7. – P. 543 – 550. 189. Yoshida K., Gould K. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular 164 ejection fraction and 3-year mortality with and without revascularization. // J. Am. Coll. Cardiol. – 1993. – Vol. 22. – № 4. – P. 984 – 997. |